Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art Review.
Pharmacological therapy
Ventricular fibrillation
Ventricular tachycardia
Journal
Heart, lung & circulation
ISSN: 1444-2892
Titre abrégé: Heart Lung Circ
Pays: Australia
ID NLM: 100963739
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
09
04
2018
revised:
28
09
2018
accepted:
01
10
2018
pubmed:
6
11
2018
medline:
17
1
2019
entrez:
6
11
2018
Statut:
ppublish
Résumé
While implantable cardioverter defibrillators decrease mortality in high risk groups of patients who have ventricular arrhythmias, antiarrhythmic drugs are still required to reduce the burden of both benign and life-threatening arrhythmias. This review will address the available medical therapy for ventricular arrhythmias in Australia and their use in different clinical situations.
Identifiants
pubmed: 30392983
pii: S1443-9506(18)31943-7
doi: 10.1016/j.hlc.2018.10.002
pii:
doi:
Substances chimiques
Anti-Arrhythmia Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-56Informations de copyright
Copyright © 2018. Published by Elsevier B.V.